
Advaxis ADXS
Annual report 2023
added 04-16-2024
Advaxis PEG Ratio 2011-2026 | ADXS
Annual PEG Ratio Advaxis
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.000022 | -0.000014 | 1.7 | 0.0115 | -0.00499 | -0.00719 | 0.117 | 0.168 | 0.0983 | -0.0423 | -0.0543 | 0.0164 | -0.0955 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.7 | -0.0955 | 0.147 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 21.65 | 1.12 % | $ 1.01 B | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
0.0951 | $ 0.9 | -0.18 % | $ 6.62 M | ||
|
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
-0.144 | $ 22.3 | 1.55 % | $ 3.7 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.000293 | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.00304 | - | -2.5 % | $ 5.88 M | ||
|
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
-7.82 | - | 17.91 % | $ 11.1 M | ||
|
BioNTech SE
BNTX
|
-12.8 | $ 102.06 | -3.22 % | $ 27.2 B | ||
|
Avenue Therapeutics
ATXI
|
-0 | - | -52.27 % | $ 4.45 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
-0.64 | $ 4.1 | 0.49 % | $ 438 M | ||
|
Arcutis Biotherapeutics
ARQT
|
0.0316 | $ 23.42 | 0.69 % | $ 2.98 B | ||
|
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.42 | -1.39 % | $ 378 M | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
AstraZeneca PLC
AZN
|
-369 | - | - | $ 96.9 B | ||
|
AVROBIO
AVRO
|
0.068 | - | 1083.1 % | $ 745 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 2.92 | -0.34 % | $ 4.81 M | ||
|
Esperion Therapeutics
ESPR
|
0.799 | $ 1.91 | - | $ 397 M | ||
|
BioDelivery Sciences International
BDSI
|
0.69 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B | ||
|
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | ||
|
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | ||
|
bluebird bio
BLUE
|
0.0148 | - | - | $ 546 M | ||
|
ContraFect Corporation
CFRX
|
-0.000085 | - | -5.16 % | $ 5.39 M | ||
|
Cardiff Oncology
CRDF
|
0.185 | $ 1.72 | - | $ 115 M | ||
|
BioXcel Therapeutics
BTAI
|
-0.000761 | $ 1.09 | 2.83 % | $ 13.3 M | ||
|
Cabaletta Bio
CABA
|
-0.01 | $ 2.91 | -1.36 % | $ 292 M | ||
|
Cara Therapeutics
CARA
|
0.00142 | - | -3.03 % | $ 260 M | ||
|
Allena Pharmaceuticals
ALNA
|
-0.0713 | - | 3.16 % | $ 1.9 M | ||
|
CASI Pharmaceuticals
CASI
|
-1.69 | - | - | $ 35.4 M |